Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Biochemical and Biophysical Research Communications|June 7, 2015
The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1(-/-) murine model of ovarian cancerJing Huang, Lei Wang, Zhongyi Cong, et al.
Gynecologic Oncology|April 1, 2014
The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1--deficient ovarian tumors and can be exploited to improve treatment response in a mouse modelGina Mantia-Smaldone, Lukas Ronner, Anne Blair, et al.
Oncogene|May 18, 2018
Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancerMiran Rada, Sameera Nallanthighal, Jennifer Cha, et al.
Science Advances|April 17, 2024
Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinomaAlexander M Xu, Marcela Haro, Ann E Walts, et al.
Cancer Research|October 16, 2010
Hippo pathway effector Yap is an ovarian cancer oncogeneChad A Hall, Runsheng Wang, Jiangyong Miao, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2007
HOXB13 promotes ovarian cancer progressionJiangyong Miao, Zuncai Wang, Heather Provencher, et al.
Cancer Research|June 5, 2007
Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancerTakiko Daikoku, Susanne Tranguch, Anindita Chakrabarty, et al.
Cancer Research|April 22, 2026
Ciliated Cells Drive Critical STING-Mediated Tumor Suppression in the Fallopian Tube EpitheliumJose A Colina, Maria Sol Recouvreux, Alexander M Sobeck, et al.
Carcinogenesis|May 1, 2015
ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinomaDong-Joo Cheon, Andrew J Li, Jessica A Beach, et al.
Oncotarget|April 17, 2017
Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMTJustyna Kanska, Paul-Joseph P Aspuria, Barbie Taylor-Harding, et al.
Pageof 13